Teva Pharmaceutical Industries Limited (TEVA) – Financial and Strategic SWOT Analysis Review

Teva Pharmaceutical Industries Limited (TEVA) – Financial and Strategic SWOT Analysis Review Cover

Single Licence: $125

Buy Now
customer(s) bought this report
BUY WITH CONFIDENCE

Shopping on CFDMaster.com is Safe and Secure. GUARANTEED!
All information is encrypted and handled by PayPal.com

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at business@cfdmaster.com or call us at +61 (02) 8011 3208
# Pages
Market
Country
Single User
Site License
Enterprisewide
83
Pharmaceuticals and Healthcare
Israel

Teva Pharmaceutical Industries Limited (TEVA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Teva Pharmaceutical Industries Limited (Teva) is a fully integrated global pharmaceutical company. It undertakes the development, manufacture and marketing of a wide range of generic and branded pharmaceuticals and active pharmaceutical ingredients (APIs). The company offers chemical and therapeutic equivalents of originator pharmaceuticals in a wide range of dosage forms, including capsules, tablets, ointments, liquids, creams, injectables and inhalants. Teva also provides an array of over the counter (OTC) products through a joint venture with P&G. The company is also a specialty pharmaceuticals innovator focusing on various disease areas including multiple sclerosis, Parkinson’s disease, autoimmune diseases, cancer, women’s health and respiratory products. Teva operates in more than 60 countries and distributes its products across the world. Teva is headquartered in Tikva, Israel.

Teva seeks to maintain and expand its leadership position in the global generics market. The company adopts organic and inorganic growth strategies to achieve its goal.

Teva Pharmaceutical Industries Limited Key Recent Developments

Mar 02, 2015: Teva Announces Sale of Sellersville, PA Facility
Feb 09, 2015: Teva Finds Likely Foreign Corrupt Practices Act Violations
Feb 09, 2015: Teva Says Copaxone Faces Increasing Competition
Feb 05, 2015: Teva Thanks Dr. Phillip Frost for Board Service
Feb 05, 2015: Teva Reports Fourth Quarter and Full Year 2014 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Table of Contents

Section 1 – About the Company 6
Teva Pharmaceutical Industries Limited – Key Facts 6
Teva Pharmaceutical Industries Limited – Key Employees 7
Teva Pharmaceutical Industries Limited – Key Employee Biographies 9
Teva Pharmaceutical Industries Limited – Major Products and Services 11
Teva Pharmaceutical Industries Limited – Pharmaceutical Pipeline Products Data 13
Teva Pharmaceutical Industries Limited, Pipeline Products by Therapy Area 13
Teva Pharmaceutical Industries Limited, Pipeline Products by Development Phase 14
Teva Pharmaceutical Industries Limited – History 20
Teva Pharmaceutical Industries Limited – Company Statement 32
Teva Pharmaceutical Industries Limited – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Joint Venture 41
Section 2 – Company Analysis 42
Teva Pharmaceutical Industries Limited – Business Description 42
Teva Pharmaceutical Industries Limited – Corporate Strategy 44
Teva Pharmaceutical Industries Limited – SWOT Analysis 45
SWOT Analysis – Overview 45
Teva Pharmaceutical Industries Limited – Strengths 45
Strength – Blockbuster Product- Copaxone 45
Strength – Specialty Medicines Portfolio 45
Strength – Cost Reduction Program 45
Teva Pharmaceutical Industries Limited – Weaknesses 46
Weakness – Decline in Revenue from Generics Segment 46
Weakness – Product Recalls Due to Manufacturing Defects 46
Weakness – Safety Issues/Product Defects 46
Teva Pharmaceutical Industries Limited – Opportunities 47
Opportunity – Strategic Acquisitions 47
Opportunity – Product Approvals and Launches 47
Opportunity – Strategic Partnerships 47
Teva Pharmaceutical Industries Limited – Threats 48
Threat – Industry Regulations 48
Threat – Competitive Pressures 48
Threat – Uncertain R&D Outcomes 48
Teva Pharmaceutical Industries Limited – Key Competitors 49
Section 3 – Company Financial Ratios 50
Financial Ratios – Capital Market Ratios 50
Financial Ratios – Annual Ratios 51
Performance Chart 53
Financial Performance 53
Financial Ratios – Interim Ratios 54
Financial Ratios – Ratio Charts 55
Section 4 – Company’s Lifesciences Financial Deals and Alliances 56
Teva Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 56
Teva Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 57
Teva Pharmaceutical Industries Limited, Medical Equipment, Deals By Year, 2009 to YTD 2015 58
Teva Pharmaceutical Industries Limited, Medical Equipment, Deals By Type, 2009 to YTD 2015 59
Teva Pharmaceutical Industries Limited, Recent Deals Summary 60
Section 5 – Company’s Recent Developments 61
Mar 02, 2015: Teva Announces Sale of Sellersville, PA Facility 61
Feb 09, 2015: Teva Finds Likely Foreign Corrupt Practices Act Violations 62
Feb 09, 2015: Teva Says Copaxone Faces Increasing Competition 63
Feb 05, 2015: Teva Thanks Dr. Phillip Frost for Board Service 64
Feb 05, 2015: Teva Reports Fourth Quarter and Full Year 2014 Results 65
Dec 11, 2014: Teva Provides 2015 Business Outlook 70
Nov 26, 2014: Prof. Yitzhak Peterburg Elected Chairman of Teva’s Board of Directors 71
Oct 30, 2014: Teva Reports Third Quarter 2014 Results 73
Oct 08, 2014: US Congress Asks 14 Pharmaceutical Companies On Escalating Drug Price 77
Oct 06, 2014: Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas 78
Section 6 – Appendix 79
Methodology 79
Ratio Definitions 79
About GlobalData 83
Contact Us 83
Disclaimer 83



List of Tables
Teva Pharmaceutical Industries Limited, Key Facts 6
Teva Pharmaceutical Industries Limited, Key Employees 7
Teva Pharmaceutical Industries Limited, Key Employee Biographies 9
Teva Pharmaceutical Industries Limited, Major Products and Services 11
Teva Pharmaceutical Industries Limited, Number of Pipeline Products by Therapy Area 13
Teva Pharmaceutical Industries Limited, Number of Pipeline Products by Development Stage 14
Teva Pharmaceutical Industries Limited, Pipeline Products By Therapy Area and Development Phase 15
Teva Pharmaceutical Industries Limited Number of Pipeline Products by Development Stage 19
Teva Pharmaceutical Industries Limited Pipeline Products by Development Stage 19
Teva Pharmaceutical Industries Limited, History 20
Teva Pharmaceutical Industries Limited, Other Locations 34
Teva Pharmaceutical Industries Limited, Subsidiaries 35
Teva Pharmaceutical Industries Limited, Joint Venture 41
Teva Pharmaceutical Industries Limited, Key Competitors 49
Teva Pharmaceutical Industries Limited, Ratios based on current share price 50
Teva Pharmaceutical Industries Limited, Annual Ratios 51
Teva Pharmaceutical Industries Limited, Interim Ratios 54
Teva Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 56
Teva Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 57
Teva Pharmaceutical Industries Limited, Medical Equipment, Deals By Year, 2009 to YTD 2015 58
Teva Pharmaceutical Industries Limited, Medical Equipment, Deals By Type, 2009 to YTD 2015 59
Teva Pharmaceutical Industries Limited, Recent Deals Summary 60
Currency Codes 79
Capital Market Ratios 79
Equity Ratios 80
Profitability Ratios 80
Cost Ratios 81
Liquidity Ratios 81
Leverage Ratios 82
Efficiency Ratios 82



List of Figures
Teva Pharmaceutical Industries Limited, Pipeline Products by Therapy Area 13
Teva Pharmaceutical Industries Limited, Pipeline Products by Development Phase 14
Teva Pharmaceutical Industries Limited Pipeline Products by Development Stage 19
Teva Pharmaceutical Industries Limited, Performance Chart (2010 – 2014) 53
Teva Pharmaceutical Industries Limited, Ratio Charts 55
Teva Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 56
Teva Pharmaceutical Industries Limited, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 57
Teva Pharmaceutical Industries Limited, Medical Equipment, Deals By Year, 2009 to YTD 2015 58
Teva Pharmaceutical Industries Limited, Medical Equipment, Deals by Type, 2009 to YTD 2015 59

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $125

Report Licences Explanation

* Single User: Electronic PDF copy delivered via email. Report can be used by individual purchaser only.

* Site License: Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.

* Enterprise Wide License: Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.

If you require a Site License or Enterprise Wide License please contact us to issue you an invoice.

Customers who Viewed this Report also Viewed

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.